Official Guidance on Live Vaccines with Cosentyx
Cosentyx (secukinumab), an IL-17A inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses immune responses. Live vaccines—such as MMR, varicella, oral polio, or yellow fever—should be avoided during treatment and for varying periods before and after.[1][2]
Prescribing information states: Do not administer live vaccines to patients on Cosentyx. Consider pausing therapy for 4-6 weeks before starting a live vaccine if needed, resuming afterward only if clinically appropriate.[1]
Why Live Vaccines Pose a Risk
Live vaccines contain weakened but replication-competent viruses or bacteria. In immunocompromised patients like those on Cosentyx, they can cause disseminated infection rather than just immunity. Cosentyx reduces IL-17 activity, impairing neutrophil function and mucosal defenses, heightening this risk.[2][3]
No fatal vaccine-related cases are reported with Cosentyx, but postmarketing data notes potential for reactivation of latent infections (e.g., TB screening required before starting).[1]
Timing Rules for Live Vaccines
| Scenario | Recommendation |
|----------|----------------|
| On active Cosentyx | Avoid live vaccines entirely |
| Before starting Cosentyx | Complete live vaccines 4+ weeks prior |
| After stopping Cosentyx | Wait 4-6 weeks post-last dose; confirm immune recovery if high-risk |
| Household exposure | No restrictions for vaccinated contacts, but monitor patient |
These align with FDA labeling and Novartis guidelines.[1][4]
What About Inactivated or Non-Live Vaccines?
Safe to use: flu shot, COVID-19 mRNA vaccines, pneumococcal, shingles (Shingrix, recombinant), Tdap. No dose adjustments needed, though antibody responses may be lower.[1][2]
Exceptions and Special Cases
- Children or pregnancy: Avoid live vaccines; consult pediatrician for catch-up schedules pre-treatment.
- Travel requirements: Defer non-essential live vaccines (e.g., typhoid oral); opt for inactivated alternatives.
- Switching biologics: If prior TNF inhibitor use, live vaccine risks compound—screen thoroughly.
Healthcare providers may assess via antibody titers or specialist input for urgent cases.[3][4]
Patient and Doctor Next Steps
Discuss full vaccination history with your rheumatologist or dermatologist before starting Cosentyx. Annual inactivated flu and pneumococcal vaccines are encouraged.[1]
Sources
[1]: Cosentyx Prescribing Information (FDA)
[2]: CDC Guidelines on Immunocompromised Patients and Vaccines
[3]: Novartis Cosentyx Safety Profile
[4]: American College of Rheumatology Biologic Guidelines